LV
Lumira Ventures
Venture CapitalActiveCanada's leading health care & life sciences venture capital firm with a 30-year reputation building companies across North America.
69
Investments
6
Exits
$500M
AUM
8.7%
Exit Rate
Get contact info, warm intros & fit scores
Sign up to unlock emails, Signal intro paths, and personalized fit analysis for Lumira Ventures.
Investment Thesis & Strategy
Lumira Ventures invests in various stages of biopharma, biotech, healthcare, health diagnostics, and information technology companies across North America, leveraging its 30-year history to build successful ventures.
Investment Activity
Deals per year over the last 15 years
1
20070
20080
20092
20100
20110
20120
20131
20141
20151
20160
20172
20180
20190
20203
2021Portfolio Companies
Selected investments from their portfolio of 69 companies
F
Field Trip Health
Healthcare · Series A, 2021
D
Deep Genomics
Biotech · Series B, 2021
C
Cyclica
Biotech · Series B, 2021
F
Fusion Pharmaceuticals
Biotech · Series B, 2018
R
Repare Therapeutics
Biotech · Series A, 2018
e
eSight
Healthcare · Series B, 2016
P
ProMIS Neurosciences
Biotech · Series A, 2015
I
IMV Inc.
Biotech · Series A, 2014
T
Therapure Biopharma
Biotech · Growth, 2010
V
VBI Vaccines
Biotech · Series A, 2010
M
Medicago
Biotech · Series A, 2007
Notable Exits
CompanyTypeYearValue / Acquirer
Field EffectAcquisition2024—
BlueDotAcquisition2024—
Integrity AdvocateAcquisition2023—
MindBridgeAcquisition2023—
Nudge.aiAcquisition2022—
DealfindAcquisition2013—
Frequently Asked Questions
Lumira Ventures focuses on Series A, Series B, Series C+ stage investments.